Top of this page
Skip navigation, go straight to the content

Clinical Studies Clinical studies index Zampilimab - UCB7858
 

Zampilimab - UCB7858

Disease area
studied
Abbreviated title Phase Study ID Registry database Study results Lay summary Publication (if available)
Chronic Allograft Injury A 2-Stage, Multicenter, Randomized, Placebo-Controlled Study to Evaluate Safety/Tolerability, Pharmacokinetics, and Efficacy of UCB7858 in Adult Kidney Transplant Recipients With Chronic Allograft Injury
Phase 1 / 2 CAI001
Ongoing
2017-004807-31